High Throughput Screening Market – Overview

High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame.

The technique has its use in the initial stages of drug discovery pathway and in toxicology studies. Since HTS enables assaying of a large set of potential biological modulators against a chosen number of defined targets, it has attained the status of being a popular approach to the target validation.

The past few years have seen the HTS market growing in a pervasive manner owing to the proliferating pharmaceutical industry and the rising adoption of HTS in drug discovery. Moreover, the rising per capita healthcare expenditures coupled with the enhanced economic conditions are accelerating the market growth of HTS.

GET FREE SAMPLE COPY OF “Global High Throughput Screening Market Research Report- Forecast To 2027” @ https://www.marketresearchfuture.com/sample_request/1280

Market Research Future’s (MRFR) extensive and in-depth study of the global High-Throughput Screening market reveals that it will grow at an impressive rate during the assessment period of 2017-2027. Mounting investments in the healthcare sector and the shifting inclination towards high throughput research is pushing the growth of the market.

The HTS market, globally, is largely driven by efficacy & safety screening, target identification & validation, and monitoring of cell-based activity. Some of the additional pointers that would support the growth of the market are the rising drug discovery initiatives by academic and government institutions, huge acceptance of open innovation models by pharmaceutical organizations.



Global High Throughput Screening Market – Segments

The MRFR analysis is segmented into four key dynamics for the convenience of understanding;

By Product Type : Software, Instruments, and Consumables among others.

By Application : Target Identification, Primary Screening, Toxicology, and Stem Cell Biology, among others.

By End-user : Hospitals, Clinics, Pharmaceutical Companies/ Manufacturers, Government Organizations, and Research Facilities among others.

By Region : North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW).

The subsegment Instruments by product types is expected to witness significant growth in demand due to its increasing use in drug discovery processes, superior performance, and reduced system cost.

Owing to the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications, the subsegment pharmaceutical, and biotechnology companies acquired the largest share in the global HTS market, by end users.



Leading Key Players

Roche (Switzerland)
Agilent Technologies Inc. (US)
Beckman Coulter, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Life Technologies Corporation (US)
Aurora Biomed Inc. (Canada)
Bio-Rad Laboratories (US)
Luminex Corporation (US)
Sigma-Aldrich Corporation. (US)
Detailed Regional Analysis

Globally, the North America region is the largest market for high throughput screening. Owing to the demanding research and development initiatives, the market is expected to grow at a significant rate of CAGR throughout the forecast period, creating a large revenue pocket by 2027. Factors substantiating the market growth include high healthcare expenditures and substantial investments in the R&D activities for medicine discovery.

Europe accounts for the second-largest market for high throughput screening which is expected to grow at a considerable CAGR during the forecast period. Favorable government support and initiatives drive the growth in the market extensively. The rapidly growing pharmaceutical sector in the region, backed by the resurging economy is fostering the market growth brilliantly.

Whereas, the Asia Pacific HTS market is growing rapidly, emerging as one of the lucrative markets, globally. Countries in the Asian region especially provide immense growth opportunities for the high-throughput screening market, accounting over half of the world’s total population. Furthermore, private equity firms and venture capitalists are increasingly investing in the HTS market in countries such as India, China, and Japan.

OBTAIN REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/high-throughput-screening-market-1280

Competitive Analysis

Feb 12, 2019, NanoTemper Technologies announced the introduction of Dianthus, a technology that boasts the capability of fast, non-stop drug discovery screening. It can be integrated into any automation solutions and workflow with absolute ease. It has no down-time and can run for 24x7 without any requirement of cleaning. The technology stands out as the new benchmark in the high-throughput screening market.

Feb 04, 2019, Ncardia, a leading organization that offers human iPSC-derived cell-based services and assays for the discovery of drug and its development, revealed the launch of its new drug screening platform called DiscoverHIT. The platform enables researchers to bring better and accurate medicines to the patients in a faster and timely manner.

Hottest Trending Reports

Cord Blood Banking Services Market Research Report - Forecast to 2023

Medical Telemetry Market Size, Share, Industry Outlook and Forecast to 2024

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]